Press release from Companies: RhoVac rapporterar delresultat om immunologiskt svar med RV001

Press release from Companies: RhoVac reports interim results on immunological response with RV001

Reports: RhoVac AB presenterar delårsrapport Q3 2019

Press release from Companies: Första patient screenad till RhoVacs kliniska fasIIb-studie

Press release from Companies: First patient screened for RhoVac"s clinical phase IIb-study

Press release from Companies: Gunnar Gårdemyr ny styrelseordförande i RhoVac

Press release from Companies: Gunnar Gårdemyr new chairman of the board of RhoVac

Press release from Companies: RhoVac erhåller godkännande i Finland för start av klinisk fas IIb-studie

Press release from Companies: RhoVac receives approval in Finland to start clinical phase IIb study in prostate cancer

More from the company: RhoVac"s evenemang under oktober - november 2019

More from the company: RhoVac"s  attending investor relation events and partnering meetings during October - November 2019

Press release from Companies: Rättelse: Kommuniké från extra bolagsstämma den 25 september 2019 i RhoVac AB